Corbus Pharmaceuticals Holdings (CRBP) Non-Current Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings has reported Non-Current Assets for 12 years, with the latest figure at $1.2 million in Q4 2025.

• On a quarterly basis, Non-Current Assets fell 57.25% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $8.0 million, a 42.34% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 57.25% from the prior year.
• Non-Current Assets was $1.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $1.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $9.9 million in Q1 2021, with the low at $1.2 million in Q4 2025.
• Average Non-Current Assets over 5 years is $5.2 million, with a median of $5.3 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Non-Current Assets slipped 6.53% in 2021, then sank 57.25% in 2025.
• Over 5 years, Non-Current Assets stood at $7.5 million in 2021, then retreated by 18.53% to $6.1 million in 2022, then dropped by 22.91% to $4.7 million in 2023, then sank by 38.57% to $2.9 million in 2024, then sank by 57.25% to $1.2 million in 2025.
• The last three Non-Current Assets figures came in at $1.2 million (Q4 2025), $1.9 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.